Weather ALERT: We are actively monitoring the weather in our area to ensure patient and staff safety. Please see our NEWS Section and social media outlets for updates throughout the coming days. Arlington Office Patients: We apologize for any inconvenience. Currently our phones are down at our Arlington office. We hope for resolution soon. If you need to reach the Arlington office, please call our main number. Thank you for your patience.
An orally bioavailable inhibitor of cell division cycle 7 (cell division cycle 7-related protein kinase; CDC7), with potential antineoplastic activity. Upon administration, TAK-931 binds to and inhibits CDC7; this prevents the initiation of DNA replication during mitosis, which causes cell cycle arrest and induces apoptosis. This inhibits cell growth in CDC7-overexpressing tumor cells. CDC7, a serine/threonine kinase and cell division cycle protein, is overexpressed in a variety of cancers and plays a key role in the activation of DNA replication and the regulation of cell cycle progression. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
